Lotemax Corticosteroid Eye Drops Effectively Treat

Inflammation in Dry Eye Disease

Lotemax (loteprednol etabonate ophthalmic suspension 0.5%) is a corticosteroid eye drop manufactured by Bausch & Lomb.  Lotemax is used for the treatment of inflammatory conditions of the conjunctiva, cornea and anterior segment of the eye.

Lotemax is contraindicated in most viral and fungal diseases of the cornea and conjunctiva.

Lotemax has a well established safety profile compared to other ophthalmic corticosteroids and has a lower incidence of causing intraocular pressure increases after prolonged use.  Lotemax is a highly effective and very safe anti-inflammatory medicine.  This makes it one of the best choices to treat ocular surface inflammation/dry eye disease.

Lotemax is used in dry eye syndrome to decrease and eliminate inflammation of the ocular surface caused by the hyperosmolarity of the tears.  The inflammation must first be brought under control before any other treatments can be optimally effective.  Lotemax would typically be prescribed for two weeks to three months initially and then may need to be used again on a 1-2 week regimen periodically if the inflammation occurs again.

Lotemax is used instead of cyclosporine drops (Restasis) by many doctors because it reduces the inflammation much faster and then can be discontinued unlike Restasis which is used every day, possibly forever, and can become rather expensive.  Restasis also can cause significant stinging upon instillation on the eye.

Lotemax must be shaken well prior to instilling the drops in the eyes.  It is available only by prescription and there is no generic available.

Lotemax is a trademark of Bausch & Lomb, Inc.

Master Eye Associates has no financial interest in this product.